Takeda Pharmaceutical
TAK
$13.39
Share price
-0.45%
Change (1 day)
-18.95%
Change (1 year)
Categories
P/S ratio for Takeda Pharmaceutical (TAK)
P/S ratio as of May 2024 (TTM): 1.43
According to Takeda Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.43168. At the end of 2023 the company had a P/S ratio of 1.54.
P/S ratio history for Takeda Pharmaceutical from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.54 | -6.32% |
| 2022 | 1.64 | 18.76% |
| 2021 | 1.38 | -26.85% |
| 2020 | 1.89 | -9.59% |
| 2019 | 2.09 | 28.42% |
| 2018 | 1.62 | -41.66% |
| 2017 | 2.78 | 36.85% |
| 2016 | 2.04 | -22.01% |
| 2015 | 2.61 | 27.24% |
| 2014 | 2.05 | -5.8% |
| 2013 | 2.18 | 18.42% |
| 2012 | 1.84 | -2.25% |
| 2011 | 1.88 | -19.67% |
| 2010 | 2.34 | 12.02% |
| 2009 | 2.09 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.10 | 186.24% | 🇺🇸 USA |
 Novartis NVS | 4.22 | 194.66% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.80 | 95.41% | 🇺🇸 USA |
 Amgen AMGN | 6.07 | 324.05% | 🇺🇸 USA |
 Sanofi SNY | 2.49 | 73.97% | 🇫🇷 France |
 Merck MRK | 5.58 | 289.57% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.43 | 69.44% | 🇬🇧 UK |
 Seagen
SGEN | 18.8 | 1,210.36% | 🇺🇸 USA |
 Dr. Reddy's RDY | 3.59 | 150.97% | 🇮🇳 India |